When should patients be referred for CAR T cell therapy?
Site Exit Disclaimer
You are now leaving the Gilead Pro website. We hope that you have found the information and resources provided helpful. The information a reader is about to be referred to may not comply with the Australian regulatory requirements. Further information relevant to the Australian environment is available from the Company or via the Product Information.